- Home
- OPRT vs FENC Comparison
OPRT vs FENC Comparison
Compare OPRT & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OPRT | FENC |
|---|---|---|
| Founded | 2005 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 249.3M | 263.3M |
| IPO Year | 2019 | 2010 |
Fundamental Metrics
Financial Performance| Metric | OPRT | FENC |
|---|---|---|
| Price | $4.24 | $7.42 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $7.25 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 644.0K | 119.0K |
| Earning Date | 05-28-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 127.18 | 96.67 |
| EPS | ★ 0.53 | N/A |
| Revenue | ★ $956,685,000.00 | $47,538,000.00 |
| Revenue This Year | $32.79 | N/A |
| Revenue Next Year | $5.51 | $70.78 |
| P/E Ratio | $8.53 | ★ N/A |
| Revenue Growth | N/A | ★ 123.69 |
| 52 Week Low | $4.06 | $4.68 |
| 52 Week High | $7.73 | $9.92 |
Technical Indicators
Market Signals| Indicator | OPRT | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 33.10 | 39.74 |
| Support Level | N/A | N/A |
| Resistance Level | $5.68 | $8.27 |
| Average True Range (ATR) | 0.31 | 0.44 |
| MACD | -0.10 | -0.09 |
| Stochastic Oscillator | 1.46 | 8.47 |
Price Performance
Historical ComparisonAbout OPRT Oportun Financial Corporation
Oportun Financial Corp is engaged in providing financial services to people who either do not have a credit score or who may have a limited credit history. The company offers Personal Loans, Auto Loans, unsecured personal loans, and secured personal loans, and provides deposit accounts, debit card services, and other transaction services to its customers. Its product offerings include small-dollar, unsecured installment loans and other products and services.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.